Skip to content

Here’s when Palantir stock will reach $50, according to analyst

Here's when Palantir stock will reach $50, according to analyst
Elmaz Sabovic

The artificial intelligence (AI) revolution is in full swing, and Wedbush analyst Dan Ives recognizes that Palantir (NYSE: PLTR) will be at the forefront of the learning process, likening its stock to the “Messi of AI” while setting a bullish price target of $50 for PLTR shares.

Here’s why Ives believes that Palantir is a perfect pick for investors looking to leverage AI advancements, suggesting it could nearly double from here with a new ‘outperform’ rating.

Firstly, the company is poised to expand its pipeline significantly as its AI platform, AIP, remains at the forefront of technological advancements. Palantir, often regarded as the “Messi of AI” by Ives, is well-positioned to capitalize on this shift. 

Secondly, since 2024 started, PLTR stock has heavily benefited from the ongoing AI revolution. It added over 70% to its value while boasting gains of 9.30% in the previous month alone.

PLTR stock 30-day price chart. Source: Finbold
PLTR stock 30-day price chart. Source: Finbold

However, it is essential to notice that PLTR shares have experienced significant volatility throughout this period and heavy short interest, which often surpassed a level of 20%. This interest has since subsided and now makes up only 4% of the available shares.

There are some stark opponents of Dan Ives’s bullish stance on PLTR stock

In a completely different opinion from Ives’s, Mizuho analyst Matthew Broome downgraded Palantir’s stock from “neutral” to “underperform” on July 16, citing its increasingly difficult-to-justify valuation. 

Despite raising the PLTR price target from $21 to $22, Broome’s PT  still suggests a 23% downside risk compared to the July 15 closing price. 

In particular, analysts at Mizuho expressed concerns about Palantir’s business’s lack of visibility despite its recent strong performance. 

Broome notes that some recent positive results are of lower quality, and he has limited confidence in Palantir’s ability to deliver strong results consistently.

Most of the Wall Street analysts seem to side with Broome, as they have a “hold” rating on PLTR shares and an average price target of $22.55, which represents a potential 20.09% downside from current price levels.

Buy stocks now with eToro – trusted and advanced investment platform

Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.